BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2574893)

  • 41. Discontinuation of neuroleptic medication in older, outpatient schizophrenics. A placebo-controlled, double-blind trial.
    Ruskin PE; Nyman G
    J Nerv Ment Dis; 1991 Apr; 179(4):212-4. PubMed ID: 1672547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptic-potentiating effect of metyrosine.
    Magelund G; Gerlach J; Casey DE
    Am J Psychiatry; 1979 May; 136(5):732. PubMed ID: 35016
    [No Abstract]   [Full Text] [Related]  

  • 43. Study of rivastigmine for delirium in intensive care is stopped after deaths.
    Sheldon T
    BMJ; 2010 May; 340():c2895. PubMed ID: 20511318
    [No Abstract]   [Full Text] [Related]  

  • 44. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Mar; 25(3):143-6. PubMed ID: 2868821
    [No Abstract]   [Full Text] [Related]  

  • 46. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gradual reduction of neuroleptic drugs among chronic schizophrenics. A double-blind controlled study.
    Lonowski DJ; Sterling FE; Kennedy JC
    Acta Psychiatr Scand; 1978 Feb; 57(2):97-102. PubMed ID: 345749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haloperidol versus chlorpromazine for treatment of schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Schizophr Bull; 2008 Sep; 34(5):813-5. PubMed ID: 18658127
    [No Abstract]   [Full Text] [Related]  

  • 49. Haloperidol decanoate in the treatment of sexual deviations.
    Zbytovský J; Zapletálek M
    Act Nerv Super (Praha); 1989 Apr; 31(1):41-2. PubMed ID: 2571225
    [No Abstract]   [Full Text] [Related]  

  • 50. Aripiprazole vs. Placebo or Haloperidol for Schizophrenia.
    Zehtabchi S
    Am Fam Physician; 2016 Dec; 94(11):877-878. PubMed ID: 27929269
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re: Clomipramine vs. Haloperidol in the treatment of autistic disorder: a double-blind, placebo, crossover study.
    King R; Fay G; Wheildon H
    J Clin Psychopharmacol; 2002 Oct; 22(5):525-6. PubMed ID: 12352279
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effects of thioridazine, flupenthixol and haloperidol on serum catalase activity in schizophrenia].
    Zapletálek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):197-204. PubMed ID: 305641
    [No Abstract]   [Full Text] [Related]  

  • 54. Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia.
    Montgomery SA; Green M; Rimon R; Heikkilä L; Forsström R; Hirsch SR; Hallstrom C; Hippius H; Naber R; Khan MC
    Acta Psychiatr Scand; 1992 Aug; 86(2):97-103. PubMed ID: 1529745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of haloperidol and thioridazine in geriatric outpatients.
    Solomon K
    J Clin Psychiatry; 1979 Nov; 40(11):495. PubMed ID: 489533
    [No Abstract]   [Full Text] [Related]  

  • 56. Benzodiazepines in chronic schizophrenia.
    Ruskin P; Averbukh I; Belmaker RH; Dasberg H
    Biol Psychiatry; 1979 Jun; 14(3):557-8. PubMed ID: 476236
    [No Abstract]   [Full Text] [Related]  

  • 57. Haloperidol vs. Low-Potency Antipsychotic Drugs for Schizophrenia.
    Bryan TL
    Am J Nurs; 2015 Jul; 115(7):21. PubMed ID: 26110946
    [No Abstract]   [Full Text] [Related]  

  • 58. The position of blonanserin as a treatment for schizophrenia.
    Kishi T; Matsuda Y; Iwata N
    Asia Pac Psychiatry; 2014 Dec; 6(4):462. PubMed ID: 25425069
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.
    Gramsch C; Emrich HM; John S; Haas S; Beckmann H; Zaudig M; von Zerssen D
    J Neural Transm; 1984; 59(2):133-41. PubMed ID: 6144724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.